Merck Sharp & Dohme Corp.;MERCK SHARP & DOHME;Merck Canada Inc.
发明人:
申请号：
EP13807800.1
公开号：
EP2863914B1
申请日:
2013.06.18
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention provides novel pyrazole derivatives of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.
